Pathfinders in Biopharma

Perspectives from the cutting edge of biotech and pharma.

The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series.

Lead today. Define tomorrow.

Featured Biopharma Content

The Optimism Behind the Biopharma Market

In this episode, Dr. Chen Yu, Founder and Managing Partner at TCG X and Noël Brown, Head of U.S. Biotechnology Investment Banking at RBC Capital Markets, discuss why they remain optimistic about biotech and what’s happening behind the scenes in public and private markets.

Listen NowRead Article

Listen Time 25mRead Time 5m

Biopharma Looks Increasingly Attractive to Investors

In a volatile market, biotech is still an underappreciated prospect, with high innovation and defensiveness to attract investors and key upcoming events that could solidify sentiment.

Read Article

Read Time 5m

Pandemic Produced Lasting Changes in Medical Device Markets

Following RBC’s Global Healthcare Conference, BioWorld MedTech published an article about the top trends discussed that will continue to reshape healthcare and medtech.

Read Article

Read Time 3m

Outlook for Healthcare Services, IT and Devices Remains Strong

Despite macroeconomic challenges, healthcare remains a strong sector for investment. Labor headwinds and inflation may temper growth in the short term, but medium- and long-term outlooks and fundamentals remain intact.

Read Article

Read Time 4m

“Large pharma has $500B it could deploy for M&A.”

What are the challenges and opportunities for the healthcare sector post-pandemic? Where might we see innovations that drive M&A growth?

Watch VideoRead Article

Watch Time 4mRead Time 3m

Biotech Investors: How to Find Value in a Bear Market

How are top investors navigating the longest biotech bear market in almost 20 years?

Listen NowRead Article

Listen Time 29mRead Time 5m

Subscribe to Future Episodes of Pathfinders

Our podcast series explores the fast-moving world of Biopharma and what the road ahead looks like for companies and investors in the sector.

Subscribe Now

Recent Deals

A Leading Partner for the Biopharma Industry

Our specialty expertise, combined with outstanding execution, has resulted in recurring transactions for biopharma clients as we partner with them through each stage of their development and growth.


More from RBC Capital Markets

Stay Informed

Get the latest insights from RBC Capital Markets delivered to your inbox.